In human ovarian cancer cells and colon cancer cells, TET2 can bind to p300 (a histone acyltransferase) and be acetylated by p300, therefore, the hydroxymethylase activity of TET2 is enhanced. Here, EP300 is linked to ovarian carcinoma.